Napabucasin Plus FOLFIRI in Patients With Previously Treated Metastatic Colorectal Cancer: Results From the Open-Label, Randomized Phase III CanStem303C Study
Titel:
Napabucasin Plus FOLFIRI in Patients With Previously Treated Metastatic Colorectal Cancer: Results From the Open-Label, Randomized Phase III CanStem303C Study
Auteur:
Shah, Manish A. Yoshino, Takayuki Tebbutt, Niall C. Grothey, Axel Tabernero, Josep Xu, Rui-Hua Cervantes, Andres Oh, Sang Cheul Yamaguchi, Kensei Fakih, Marwan Falcone, Alfredo Wu, Christina Chiu, Vi K. Tomasek, Jiri Bendell, Johanna Fontaine, Marilyn Hitron, Matthew Xu, Bo Taieb, Julien Van Cutsem, Eric